Literature DB >> 10348461

Pathophysiology of chorea and bradykinesia in Huntington's disease.

A Berardelli1, J Noth, P D Thompson, E L Bollen, A Currà, G Deuschl, J G van Dijk, R Töpper, M Schwarz, R A Roos.   

Abstract

This article reviews the neurophysiological abnormalities described in Huntington's disease. Among the typical features of choreic movements are variable and random patterns of electromyographic (EMG) activity, including cocontraction of agonist and antagonist muscles. Studies of premotor potentials show that choreic movements are not preceded by a Bereitschaftspotential, therefore demonstrating that choreic movement is involuntary. Early cortical median-nerve somatosensory-evoked potentials have reduced amplitudes and the reduction correlates with reduced glucose consumption in the caudate nucleus. Long-latency stretch reflexes evoked in the small hand muscles are depressed. These findings may reflect failed thalamocortical relay of sensory information. In Huntington's disease, the R2 response of the blink reflex has prolonged latencies, diminished amplitudes, and greater habituation than normal. These abnormalities correlate with the severity of chorea in the face. Patients with Huntington's disease perform simple voluntary movements more slowly than normal subjects and with an abnormal triphasic EMG pattern. Bradykinesia is also present during their performance of simultaneous and sequential movements. Eye movements show abnormalities similar to those seen in arm movements. In Huntington's disease, arm movement execution is associated with reduced PET activation of cortical frontal areas. Studies using transcranial magnetic stimulation show that patients with Huntington's disease have normal corticospinal conduction but some patients have a prolonged cortical silent period. Bradykinesia results from degeneration of the basal ganglia output to the supplementary motor areas concerned with the initiation and maintenance of sequential movements. The coexisting hyperkinetic and hypokinetic movement disorders in patients with Huntington's disease probably reflect the involvement of direct and indirect pathways in the basal ganglia-thalamus-cortical motor circuit.

Entities:  

Mesh:

Year:  1999        PMID: 10348461     DOI: 10.1002/1531-8257(199905)14:3<398::aid-mds1003>3.0.co;2-f

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  21 in total

Review 1.  Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.

Authors:  Ina Han; YiMei You; Jeffrey H Kordower; Scott T Brady; Gerardo A Morfini
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

2.  Decreased Lin7b expression in layer 5 pyramidal neurons may contribute to impaired corticostriatal connectivity in huntington disease.

Authors:  Birgit Zucker; Jibrin A Kama; Alexandre Kuhn; Doris Thu; Lianna R Orlando; Anthone W Dunah; Ozgun Gokce; David M Taylor; Johann Lambeck; Bernd Friedrich; Katrin S Lindenberg; Richard L M Faull; Cornelius Weiller; Anne B Young; Ruth Luthi-Carter
Journal:  J Neuropathol Exp Neurol       Date:  2010-09       Impact factor: 3.685

3.  Striatal volume differences between non-human and human primates.

Authors:  Dali Yin; Francisco E Valles; Massimo S Fiandaca; John Forsayeth; Paul Larson; Phillip Starr; Krystof S Bankiewicz
Journal:  J Neurosci Methods       Date:  2008-09-02       Impact factor: 2.390

4.  Biallelic Mutations in PDE10A Lead to Loss of Striatal PDE10A and a Hyperkinetic Movement Disorder with Onset in Infancy.

Authors:  Christine P Diggle; Stacey J Sukoff Rizzo; Michael Popiolek; Reetta Hinttala; Jan-Philip Schülke; Manju A Kurian; Ian M Carr; Alexander F Markham; David T Bonthron; Christopher Watson; Saghira Malik Sharif; Veronica Reinhart; Larry C James; Michelle A Vanase-Frawley; Erik Charych; Melanie Allen; John Harms; Christopher J Schmidt; Joanne Ng; Karen Pysden; Christine Strick; Päivi Vieira; Katariina Mankinen; Hannaleena Kokkonen; Matti Kallioinen; Raija Sormunen; Juha O Rinne; Jarkko Johansson; Kati Alakurtti; Laura Huilaja; Tiina Hurskainen; Kaisa Tasanen; Eija Anttila; Tiago Reis Marques; Oliver Howes; Marius Politis; Somayyeh Fahiminiya; Khanh Q Nguyen; Jacek Majewski; Johanna Uusimaa; Eamonn Sheridan; Nicholas J Brandon
Journal:  Am J Hum Genet       Date:  2016-04-07       Impact factor: 11.025

5.  Role of hypokinesia and bradykinesia in gait disturbances in Huntington's disease: a biomechanical study.

Authors:  Arnaud Delval; Pierre Krystkowiak; Jean-Louis Blatt; Etienne Labyt; Kathy Dujardin; Alain Destée; Philippe Derambure; Luc Defebvre
Journal:  J Neurol       Date:  2005-08-17       Impact factor: 4.849

6.  Echogenicity of basal ganglia structures in different Huntington's disease phenotypes.

Authors:  Carsten Saft; Rainer Hoffmann; Katrin Strassburger-Krogias; Thomas Lücke; Saskia H Meves; Gisa Ellrichmann; Christos Krogias
Journal:  J Neural Transm (Vienna)       Date:  2014-12-13       Impact factor: 3.575

7.  Characteristics and occurrence of speech impairment in Huntington's disease: possible influence of antipsychotic medication.

Authors:  Jan Rusz; Jiří Klempíř; Tereza Tykalová; Eva Baborová; Roman Čmejla; Evžen Růžička; Jan Roth
Journal:  J Neural Transm (Vienna)       Date:  2014-05-09       Impact factor: 3.575

8.  The relationship between impairment of voluntary movements and cognitive impairment in Huntington's disease.

Authors:  Jirí Klempír; Olga Klempírová; Jan Stochl; Natasa Spacková; Jan Roth
Journal:  J Neurol       Date:  2009-05-16       Impact factor: 4.849

Review 9.  Evolving concepts on bradykinesia.

Authors:  Matteo Bologna; Giulia Paparella; Alfonso Fasano; Mark Hallett; Alfredo Berardelli
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

10.  Saccadic impairments in Huntington's disease.

Authors:  A Peltsch; A Hoffman; I Armstrong; G Pari; D P Munoz
Journal:  Exp Brain Res       Date:  2008-01-10       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.